ATNM
#4441
Actinium Pharmaceuticals, Inc. Common Stock
1.0 1 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.98%
Monthly Change
+20.24%
6 month change
-12.17%
Year Change
-2.88%
Previous Close
1.0 2
Open
1.0 0
Low
1.0 0
High
1.0 1
Volume
8
Financials
- Market Capitalization 31.76 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.25
Price to sales ratio
471.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4431 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.73 USD | +0.54% | -7.67% | +6.88% | -51.24% | 32.45 M USD | ||
| 4437 |  IGC IGC Pharma, Inc. Common Stock | 0.31 USD | -6.06% | +3.33% | +24.00% | +21.00% | 32.05 M USD | ||
| 4445 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.71 USD | -1.39% | -6.58% | -6.58% | -33.02% | 30.88 M USD | ||
| 4449 |  BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.75 USD | 0.00% | +19.05% | +36.36% | -39.02% | 30.64 M USD |
Frequently asked questions about Actinium Pharmaceuticals, Inc
What is the Actinium Pharmaceuticals, Inc stock price today?
The current price of Actinium Pharmaceuticals, Inc (ATNM) is 1.01. Over the past 24 hours, the stock has changed by -0.98%. Follow the ATNM chart for real-time price dynamics.
What is the stock ticker of Actinium Pharmaceuticals, Inc?
Actinium Pharmaceuticals, Inc trades under the ticker ATNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Actinium Pharmaceuticals, Inc stock going up?
ATNM has changed by -5.61% over the last week, +20.24% over the last month, and -2.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Actinium Pharmaceuticals, Inc?
Actinium Pharmaceuticals, Inc currently has a market capitalization of 31.76 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Actinium Pharmaceuticals, Inc earnings last quarter?
Last quarter, Actinium Pharmaceuticals, Inc reported earnings of 0.89 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Actinium Pharmaceuticals, Inc revenue for the last quarter?
Actinium Pharmaceuticals, Inc reported quarterly revenue of 35 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Actinium Pharmaceuticals, Inc net income for the last quarter?
Actinium Pharmaceuticals, Inc reported net income of 27.9 M for the last quarter. The previous quarter showed -5.52 M, which means net income changed by +605.27%.
How many employees does Actinium Pharmaceuticals, Inc have?
As of the latest available data, Actinium Pharmaceuticals, Inc has 25 employees. Workforce size can provide additional context about the company's scale and operations.
What is Actinium Pharmaceuticals, Inc EBITDA?
Actinium Pharmaceuticals, Inc EBITDA is 28 M, and its EBITDA margin is 79.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Actinium Pharmaceuticals, Inc stock?
You can buy Actinium Pharmaceuticals, Inc (ATNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Actinium Pharmaceuticals, Inc stock?
Investing in Actinium Pharmaceuticals, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ATNM chart and related analysis on metatrader.com as part of your research.